In 2023, the Diosmin API market was valued at approximately USD XX billion and is projected to surpass USD XX billion by 2032, growing at a steady CAGR of XX%. This growth is largely attributed to the global prevalence of vein-related disorders, sedentary lifestyles, and aging populations.